Mexico Veterinary In Vitro Fertilization Market Size & Outlook, 2026-2034
Mexico Veterinary In Vitro Fertilization Market Insights
- As per Reed Intelligence insights, the Mexico Veterinary In Vitro Fertilization Market stood at USD 20.23 Million in 2025 and is anticipated to grow to USD 45.53 Million by 2034.
- The Mexico market is expected to advance at a CAGR of 9.46% from 2026 through 2034.
- In 2025, Livestock accounted for the highest share of the Animal Type market size.
- During the forecast period, Companion Animals is set to register the highest growth, making it the most lucrative Animal Type segment.
Source: RI Analysis Company Publications, Primary Interviews.
Other Key Findings
- As of 2025, Mexico held 1.93% of the global Veterinary In Vitro Fertilization Market size.
- By 2034, United States is anticipated to capture the largest share of the global Veterinary In Vitro Fertilization Market.
- In LATAM, Brazil is expected to lead the regional Veterinary In Vitro Fertilization Market size by 2034.
- Brazil will remain the fastest-growing market in LATAM, reaching USD 65.08 Million by 2034.
Report Summary
| Report Scope | Details |
|---|---|
| Base Year for Study | 2025 |
| Study Period | 2022-2034 |
| Historical Period | 2022-2024 |
| Forecast Period | 2026-2034 |
| Market Size In 2025 | USD 20.23 Million |
| Market Size In 2034 | USD 45.53 Million |
| Largest segment | Livestock |
| Units | Revenue in USD Million |
| CAGR | 9.46% (2026-2034) |
| Segmnetation Covered | |
| Animal Type |
|
| Technology |
|
| Application |
|
| End-Use |
|
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends |
Mexico Veterinary In Vitro Fertilization Market Animal Type 2026-2034 (USD Million)
| Animal Type | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Livestock | XX.x | XX.x | XX.x | 9.15 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Companion Animals | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Wildlife Conservation Animals | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: RI Analysis Company Publications, Primary Interviews.
Mexico Veterinary In Vitro Fertilization Market Technology 2026-2034 (USD Million)
| Technology | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Conventional In Vitro Fertilization (IVF) | XX.x | XX.x | XX.x | 9.2 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Intracytoplasmic Sperm Injection (ICSI) | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Embryo Culture Cryopreservation | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: RI Analysis Company Publications, Primary Interviews.
Mexico Veterinary In Vitro Fertilization Market Application 2026-2034 (USD Million)
| Application | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Livestock Breeding | XX.x | XX.x | XX.x | 9.15 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Genetic Preservation | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Veterinary Research | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: RI Analysis Company Publications, Primary Interviews.
Mexico Veterinary In Vitro Fertilization Market End-Use 2026-2034 (USD Million)
| End-Use | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Veterinary Hospitals Fertility Clinics | XX.x | XX.x | XX.x | 9.8 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Biotechnology Laboratories | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Research Institutes | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: RI Analysis Company Publications, Primary Interviews.
